Impact of COVID-19 PandemicThe potential advantage of NGS diagnostic technology was to determining the genetic sequence of a virus and helping scientists understand the change of the virus.
In 2020, the (US FDA) United States Food and Drug Administration issued an emergency use authorized (EUA) to Illumina Inc. for the first COVID-19 diagnostic test adopting NGS technology.
Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=next-generation-sequencing-market-p.php Based on TypeNext Generation Sequencing Market includes Targeted Re-sequencing (TPS/WES), RNA-Sequencing, Whole Genome Sequencing, Chip-Sequencing, De Novo Sequencing, and Methyl-Sequencing.
They were operating in the global next-generation sequencing market.
Renub Research latest report “Next-generation sequencing Market by Types of Test (Targeted Re-sequencing (TPS/WES), RNA-Sequencing, Whole Genome Sequencing, ChIP-Sequencing, De Novo Sequencing, and Methyl-Sequencing) by Disease (Reproductive Health NGS test , NGS Test Market (Rare Disease Diagnostics), Cancer (Risk Prediction, therapy Selection & Respose), Metabolic Immune (Diagnostic), Cardiovascular NGS Test Market, Others NGS Test Market) by Informatics (NGS Informatics Services, Primary and Secondary Data Analysis Tools, Computing, Storage, Biological Interpretation and Reporting Tools, LIMS (Laboratory Information Management System) by End User (Academic and Research Institutes, Biopharmaceutical Industry, Diagnostics Industry, Governments Agencies, Hospitals and Clinics)" provides a detailed analysis of Next-generation sequencing Industry.
Follow the link for the full report with detailed TOC and list of figures and tables: https://www.renub.com/next-generation-sequencing-market-p.php Types of Test - Next Generation Sequencing Market have been covered from 6 viewpoints:1.